Strengthening Direct Marketing Through the Acquisition of All Shares in マルマンH&B
First written in FY2020. 12 of 14 entries say "Advanced", first in FY2021-Q1. Latest entry: FY2026-H1.
No other company in this theme has enough history to compare yet.
- FY2026-H1AdvancedAnnual report
「In the cosmetics manufacturing and sales division, sales and profits both remained strong due to strong sales of Korean cosmetics, including Torriden, and lower selling, general and administrative expenses in the mail-order cosmetics business resulting from the withdrawal from certain categories and improvements in advertising and sales promotion.」
Sales and profit were strong as sales of Korean cosmetics, including Torriden, performed well in the direct marketing business, while selling, general and administrative expenses also declined following the reorganisation of the mail-order cosmetics categories and improvements in advertising and sales promotion. - 2026-04-13AdvancedEarnings
「In the cosmetics manufacturing and sales division, sales of the imported cosmetics brand “Torriden” continued to grow from the previous fiscal year, while sales expansion resulting from the rebranding of core products in the mail-order cosmetics business also contributed, resulting in strong performance in both sales and profit.」
The company cited continued growth in Torriden sales and sales expansion from the rebranding of core mail-order cosmetics products. - FY2025-H1AdvancedAnnual report
「In the imported cosmetics and proprietary products business, sales increased substantially, helped by strong sales of the proprietary product “Pureal (ピュレア)” and the effect of new-product sales in the “Torriden (トリデン)” series of imported Korean cosmetics.」
Through direct marketing by Maruman H&B and others, sales of Pureal and Torriden increased substantially. - FY2024AdvancedAnnual report
「Performance at マルマンＨ＆Ｂ株式会社 increased substantially as sales of the proprietary cosmetics product “Pureal (ピュレア)” and the imported cosmetics product “Torriden (トリデン)” remained strong.」
Through direct marketing by Maruman H&B, strong sales of Pureal and Torriden continued, and performance increased substantially. - FY2024-Q2AdvancedAnnual report
「Performance in the mail-order cosmetics business increased substantially as sales of the proprietary cosmetics product “Pureal” and the imported cosmetics product “Torriden (トリデン)” remained strong.」
Through direct marketing by Maruman H&B and others, sales of “Pureal” and “Torriden” remained strong, and performance in the mail-order cosmetics business increased substantially. - FY2023-Q3RestatedAnnual report
「In addition, sales of in-house health food products, the sheet mask “Pureal” and imported cosmetics at マルマンＨ＆Ｂ株式会社 remained solid.」
Strong sales of in-house health food products, the sheet mask “Pureal” and imported cosmetics have continued since the acquisition of Maruman H&B. - FY2023-Q2AdvancedAnnual report
「In addition, sales of the sheet mask “Pureal,” in-house health food products and imported cosmetics at マルマンＨ＆Ｂ株式会社 remained strong.」
Sales of Maruman H&B’s proprietary sheet masks, in-house health food products and imported cosmetics remained strong. - FY2023-Q1AdvancedAnnual report
「マルマンＨ＆Ｂ株式会社, an affiliated company, performed well in sales of its own health foods and sheet masks and imported cosmetics that it handles.」
Following the acquisition of マルマンH&B, sales of the Company's proprietary health foods, sheet masks and imported cosmetics performed well. - FY2022AdvancedAnnual report
「In the product planning business, the Company's proprietary product Pureal performed well, while EC sales also performed well, supported by a Korean cosmetics campaign.」
Following the acquisition of マルマンH&B, EC sales of the Company's proprietary Pureal brand and Korean cosmetics performed well in the direct marketing business. - FY2022-Q3AdvancedAnnual report
「In addition to the Korean cosmetics handled by マルマンＨ＆Ｂ株式会社, sales of the Company's proprietary sheet mask brand Pureal grew steadily and performed well.」
In addition to the Korean cosmetics handled by マルマンH&B, sales of the Company's proprietary Pureal sheet mask brand grew. - FY2022-Q1AdvancedAnnual report
「As a result, the Food Business and マルマンＨ＆Ｂ株式会社, which became a consolidated subsidiary in December 2020, performed well, and signs of improvement emerged, including an increase in the year-on-year sales of raw materials for the Company's proprietary cosmetics products.」
After the acquisition of マルマンH&B, the company and the Food Business performed well, and sales of raw materials for the Company's proprietary cosmetics products increased year on year. - FY2021-Q2AdvancedAnnual report
「As a result, the Food Business and マルマンＨ＆Ｂ株式会社, which became a consolidated subsidiary in December 2020, performed well, and signs of improvement emerged, including an increase in the year-on-year sales of raw materials for the Company's proprietary cosmetics products.」
After the acquisition of マルマンH&B, the company and the Food Business performed well, and sales of raw materials for the Company's proprietary cosmetics products increased year on year. - FY2021-Q1AdvancedAnnual report
「As a result, the Food Business and マルマンＨ＆Ｂ株式会社, which became a consolidated subsidiary in December 2020, performed well, and signs of improvement emerged, including an increase in the year-on-year sales of raw materials for the Company's proprietary cosmetics products.」
The Company reported that the Food Business and マルマンH&B performed well in the first quarter after its acquisition. However, the HBC and Food Business as a whole performed poorly due to the spread of COVID-19. - FY2020AchievedAnnual report
「At a meeting of its board of directors held on 19 November 2020, the Company resolved to acquire all shares of マルマンＨ＆Ｂ株式会社 held by マジェスティゴルフ株式会社 and make マルマンＨ＆Ｂ a wholly owned subsidiary. The Company acquired all shares effective 18 December 2020.」
The Company completed the transaction to acquire マルマンH&B, which sells health foods, cosmetics and other products, with the aim of complementing the value chain of the HBC and Food Business and expanding its direct marketing business. The acquisition cost was ¥1 billion.